Page last updated: 2024-10-25

clonidine and Pheochromocytoma

clonidine has been researched along with Pheochromocytoma in 92 studies

Clonidine: An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION.
clonidine (amino form) : A clonidine that is 4,5-dihydro-1H-imidazol-2-amine in which one of the amino hydrogens is replaced by a 2,6-dichlorophenyl group.

Pheochromocytoma: A usually benign, well-encapsulated, lobular, vascular tumor of chromaffin tissue of the ADRENAL MEDULLA or sympathetic paraganglia. The cardinal symptom, reflecting the increased secretion of EPINEPHRINE and NOREPINEPHRINE, is HYPERTENSION, which may be persistent or intermittent. During severe attacks, there may be HEADACHE; SWEATING, palpitation, apprehension, TREMOR; PALLOR or FLUSHING of the face, NAUSEA and VOMITING, pain in the CHEST and ABDOMEN, and paresthesias of the extremities. The incidence of malignancy is as low as 5% but the pathologic distinction between benign and malignant pheochromocytomas is not clear. (Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1298)

Research Excerpts

ExcerptRelevanceReference
" We aimed to evaluate the role of the clonidine suppression test (CST) in the era of analyses of plasma-free metanephrines for the diagnosis or exclusion of PPGL in patients with adrenal tumours and/or arterial hypertension."9.51Clonidine suppression test for a reliable diagnosis of pheochromocytoma: When to use. ( Dralle, H; Führer, D; Geroula, A; Pamporaki, C; Schmid, KW; Tsiomidou, S; Unger, N; Van Baal, L; Weber, F, 2022)
"The diagnosis of pheochromocytoma/paraganglioma (PPGL) involves detection of elevated levels of plasma and/or 24-h urine catecholamines and/or their metabolites, including metanephrines."7.81Urinary clonidine suppression testing for the diagnosis of pheochromocytoma. ( Fountoulakis, S; Gordon, RD; Goupil, R; Stowasser, M, 2015)
"The clonidine test has been proposed as diagnostic biochemical test for patients with clinical suspicion of pheochromocytoma."7.71[Usefulness of the clonidine test for the diagnosis of pheochromocytoma]. ( Fernández-Torres, C; Hidalgo Tenorio, C; Jiménez-Alonso, J; León-Ruiz, L; López de la Torre Casares, M; Mediavilla García, JD; Piédrola Maroto, G; Pinel Julián, P, 2001)
"Recent investigations have shown that the widely used clonidine suppression test is sometimes fallible for the diagnosis of pheochromocytoma."7.68Evaluation of clonidine suppression and various provocation tests in the diagnosis of pheochromocytoma. ( Ikeda, M; Koshida, H; Matsubara, T; Miyamori, I; Okamoto, S; Soma, R; Takeda, R, 1990)
"The intent of this study is to retrospectively evaluate our experience, as well as all published information, regarding the clonidine suppression test to determine its utility, accuracy, and safety in the diagnosis of pheochromocytoma."7.68The clonidine suppression test for pheochromocytoma. A review of its utility and pitfalls. ( Kidd, GS; Simcic, KJ; Sjoberg, RJ, 1992)
"Authors assessed correlation between venous blood catecholamines and prostaglandins concentrations before and after inhibition of sympathetic activity by clonidine in patients with primary hypertension or pheochromocytoma."7.68[Correlations between catecholamines and prostaglandins in patients with primary arterial hypertension and pheochromocytoma in basic conditions and after administration of clonidine]. ( Bar-Andziak, E; Chojnowski, K; Feltynowski, T; Ignatowska-Switalska, H; Lazecki, D; Wocial, B, 1990)
"We assessed the sensitivity and specificity of glucagon stimulation and clonidine suppression tests in the diagnosis of pheochromocytoma in 113 hypertensive patients, 39 with and 74 without the tumor."7.68Glucagon and clonidine testing in the diagnosis of pheochromocytoma. ( Goldstein, DS; Grossman, E; Hoffman, A; Keiser, HR, 1991)
"The role of the clonidine suppression test and determination of the plasma concentration of noradrenaline and of neuropeptide Y (NPY) for the diagnosis and monitoring of bilateral pheochromocytoma was studied in a ten year old girl."7.68[Bilateral adrenal pheochromocytoma. Diagnosis and follow-up using the clonidine test and measurement of plasma neuropeptide Y concentration]. ( Eisenhut, S; Lang, RE; Rascher, W, 1990)
" They investigated therefore in 15 patients with essential hypertension (EH) and in three patients with pheochromocytoma the urinary excretion of free noradrenaline (NA), adrenaline (A) and dopamine (DA), the plasma renin activity (PRA), the aldosterone concentration (PAC) and atrial natriuretic factor (ANF) in plasma, using radioimmunoanalysis, always before and 24 hours after clonidine administration (Haemiton retardR) by the oral route."7.68[The effect of clonidine on humoral factors in patients with arterial hypertension]. ( Dvoráková, J; Gregorová, I; Horký, K; Kopecká, J; Poliak, M, 1990)
"23 patients presenting with symptoms of pheochromocytoma were subjected to the clonidine suppression test."7.67Preliminary results with the clonidine suppression test in the diagnosis of pheochromocytoma. ( Beyer, J; Brandstetter, K; Krause, U, 1985)
"A clonidine-suppression test was carried out in 8 patients with arterial hypertension, raised urinary and plasma catecholamine levels and symptoms suggesting the presence of a pheochromocytoma."7.67[The clonidine inhibition test: an aid in the diagnosis and postoperative therapeutic control in pheochromocytoma]. ( Schofer, J; Tews, A, 1985)
"Baseline plasma norepinephrine (NE) and epinephrine (E) levels over 2000 pg/ml or failure to suppress to less than 500 pg/ml after oral clonidine have been considered diagnostic of the presence of a pheochromocytoma."7.67Clonidine suppression test for pheochromocytoma: examples of misleading results. ( Anton, AH; Mayes, D; Taylor, HC, 1986)
" The clonidine suppression of urinary metanephrines as a criterion for the diagnosis of pheochromocytoma is described."7.67The clonidine test for the diagnosis of pheochromocytoma: the usefulness of urinary metanephrine measurements. ( Andriollo, A; Carvalho, JG; Guerra, EM; Kohlmann, O; Mulinari, RA; Ribeiro, AB; Saad, CI; Zanella, MT, 1987)
"In a prospective study designed to differentiate pheochromocytoma from other forms of hypertension, urinary catecholamines were measured after sleep and clonidine administration in 12 patients with pheochromocytoma, 19 hypertensive patients in whom pheochromocytoma was suspected but later excluded, and 31 hypertensive patients in whom pheochromocytoma was never suspected."7.67Overnight clonidine suppression test in the diagnosis and exclusion of pheochromocytoma. ( Ball, SG; Finlayson, J; Inglis, GC; Isles, CG; Lees, KR; Macdougall, IC; McMillan, NC; Morley, P; Stewart, H; Thomson, I, 1988)
"A clonidine suppression test and the measurement of the catecholamine (noradrenaline and adrenaline) concentration in 24-hour urine were undertaken on 13 patients with benign phaeochromocytoma (PCC), 30 patients with benign hypertension (BHT) and ten healthy, normotensive volunteers."7.67[Diagnostic significance of the clonidine suppression test in suspected pheochromocytoma]. ( Ivens, K; Schürmeyer, T; Stimpel, M; Volkmann, HP; von zur Mühlen, A; Wambach, G, 1988)
"In this study we examined the preoperative value of the clonidine-suppression test in 15 patients with surgically proved pheochromocytomas."7.67Evaluation of the clonidine-suppression test in the diagnosis of pheochromocytoma. ( Beyer, J; Cordes, U; Krause, U; Plewe, G, 1988)
"In the present paper we report our experience on the utility of basal plasma catecholamine (CA) measurement and of the clonidine-suppression test in the diagnosis of pheochromocytoma."7.67Usefulness of basal catecholamine plasma levels and clonidine suppression test in the diagnosis of pheochromocytoma. ( Baldi, E; De Feo, ML; Maggi, M; Mannelli, M; Opocher, G; Pupilli, C; Serio, M; Valenza, T, 1987)
"To investigate the possible release of beta-endorphins (beta EN) from tumors and to investigate their possible involvement in the hypotensive mechanism of clonidine (CLO) in pheochromocytoma (PHEO), as compared with essential hypertension (EH), we studied 12 patients with PHEO, 17 patients with uncomplicated stable EH (SEH), nine patients with borderline EH (BEH), and seven healthy volunteers (N)."7.67Plasma beta-endorphins and catecholamines before and after clonidine in essential hypertension and pheochromocytoma. ( Chodakowska, J; Chojnowski, K; Feltynowski, T; Januszewicz, W; Lazecki, D; Wocial, B, 1987)
" Clonidine testing resulted in suppression of plasma norepinephrine levels but was complicated by severe hypotension and a transient ischemic attack."7.66Symptomatic hypotension following the clonidine suppression test for pheochromocytoma. ( Dzau, VJ; Given, BD; Lilly, LS; Taylor, T, 1983)
"1 We have compared, in patients with severe hypertension, the administration of intravenous labetalol by single rapid injection, by repeated bolus injections, and by incremental infusion."7.66Intravenous labetalol in the treatment of severe hypertension. ( Brown, JJ; Cumming, AM; Lever, AF; Robertson, JI, 1982)
" We aimed to evaluate the role of the clonidine suppression test (CST) in the era of analyses of plasma-free metanephrines for the diagnosis or exclusion of PPGL in patients with adrenal tumours and/or arterial hypertension."5.51Clonidine suppression test for a reliable diagnosis of pheochromocytoma: When to use. ( Dralle, H; Führer, D; Geroula, A; Pamporaki, C; Schmid, KW; Tsiomidou, S; Unger, N; Van Baal, L; Weber, F, 2022)
"6 Labetalol is a useful addition to the medical treatment of phaeochromocytoma."5.26Treatment of phaeochromocytoma and of clonidine withdrawal hypertension with labetalol. ( Brown, JJ; Lever, AF; Robertson, AS; Robertson, JI; Rosei, EA; Trust, PM, 1976)
"The purpose of this paper is to report our experience and to review the published data on the diagnostic significance and risks of the clonidine suppression test in the diagnosis of pheochromocytoma."4.80Clonidine suppression test revisited. ( Geiger, H; Lenz, T; Ross, A; Schulte, KL; Schumm-Draeger, P, 1998)
" It has also been used intravenously in phaeochromocytoma, tetanus, clonidine withdrawal, and as an adjunct to halothane to produce hypotensive anaesthesia."4.76Combined alpha- and beta-receptor inhibition in the treatment of hypertension. ( Prichard, BN, 1984)
"Moderately elevated plasma normetanephrine (NMN) levels are frequent among patients with suspected pheochromocytoma and paraganglioma (PPGL)."4.12Improved Diagnostic Accuracy of Clonidine Suppression Testing Using an Age-Related Cutoff for Plasma Normetanephrine. ( Deutschbein, T; Eisenhofer, G; Fassnacht, M; Fuss, CT; Masjkur, J; Nölting, S; Pamporaki, C; Prejbisz, A; Quinkler, M; Remde, H; Timmers, HJLM, 2022)
"The diagnosis of pheochromocytoma/paraganglioma (PPGL) involves detection of elevated levels of plasma and/or 24-h urine catecholamines and/or their metabolites, including metanephrines."3.81Urinary clonidine suppression testing for the diagnosis of pheochromocytoma. ( Fountoulakis, S; Gordon, RD; Goupil, R; Stowasser, M, 2015)
"The aim of this study is to review the experience of the clonidine suppression test in a regional endocrine centre and to compare the diagnostic sensitivity and specificity using various previous published criteria."3.77Evaluation of the clonidine suppression test in the diagnosis of phaeochromocytoma. ( Atkinson, AB; Hunter, SJ; McCormick, MT; McHenry, CM; Russell, CF; Smye, MG, 2011)
"Measurements of plasma normetanephrine and metanephrine provide a highly sensitive test for diagnosis of pheochromocytoma, but false-positive results remain a problem."3.72Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test results. ( Eisenhofer, G; Friberg, P; Goldstein, DS; Keiser, HR; Lenders, JW; Pacak, K; Walther, MM, 2003)
"The clonidine test has been proposed as diagnostic biochemical test for patients with clinical suspicion of pheochromocytoma."3.71[Usefulness of the clonidine test for the diagnosis of pheochromocytoma]. ( Fernández-Torres, C; Hidalgo Tenorio, C; Jiménez-Alonso, J; León-Ruiz, L; López de la Torre Casares, M; Mediavilla García, JD; Piédrola Maroto, G; Pinel Julián, P, 2001)
"Authors assessed correlation between venous blood catecholamines and prostaglandins concentrations before and after inhibition of sympathetic activity by clonidine in patients with primary hypertension or pheochromocytoma."3.68[Correlations between catecholamines and prostaglandins in patients with primary arterial hypertension and pheochromocytoma in basic conditions and after administration of clonidine]. ( Bar-Andziak, E; Chojnowski, K; Feltynowski, T; Ignatowska-Switalska, H; Lazecki, D; Wocial, B, 1990)
"We assessed the sensitivity and specificity of glucagon stimulation and clonidine suppression tests in the diagnosis of pheochromocytoma in 113 hypertensive patients, 39 with and 74 without the tumor."3.68Glucagon and clonidine testing in the diagnosis of pheochromocytoma. ( Goldstein, DS; Grossman, E; Hoffman, A; Keiser, HR, 1991)
"Recent investigations have shown that the widely used clonidine suppression test is sometimes fallible for the diagnosis of pheochromocytoma."3.68Evaluation of clonidine suppression and various provocation tests in the diagnosis of pheochromocytoma. ( Ikeda, M; Koshida, H; Matsubara, T; Miyamori, I; Okamoto, S; Soma, R; Takeda, R, 1990)
"The intent of this study is to retrospectively evaluate our experience, as well as all published information, regarding the clonidine suppression test to determine its utility, accuracy, and safety in the diagnosis of pheochromocytoma."3.68The clonidine suppression test for pheochromocytoma. A review of its utility and pitfalls. ( Kidd, GS; Simcic, KJ; Sjoberg, RJ, 1992)
" They investigated therefore in 15 patients with essential hypertension (EH) and in three patients with pheochromocytoma the urinary excretion of free noradrenaline (NA), adrenaline (A) and dopamine (DA), the plasma renin activity (PRA), the aldosterone concentration (PAC) and atrial natriuretic factor (ANF) in plasma, using radioimmunoanalysis, always before and 24 hours after clonidine administration (Haemiton retardR) by the oral route."3.68[The effect of clonidine on humoral factors in patients with arterial hypertension]. ( Dvoráková, J; Gregorová, I; Horký, K; Kopecká, J; Poliak, M, 1990)
"The role of the clonidine suppression test and determination of the plasma concentration of noradrenaline and of neuropeptide Y (NPY) for the diagnosis and monitoring of bilateral pheochromocytoma was studied in a ten year old girl."3.68[Bilateral adrenal pheochromocytoma. Diagnosis and follow-up using the clonidine test and measurement of plasma neuropeptide Y concentration]. ( Eisenhut, S; Lang, RE; Rascher, W, 1990)
"A clonidine-suppression test was carried out in 8 patients with arterial hypertension, raised urinary and plasma catecholamine levels and symptoms suggesting the presence of a pheochromocytoma."3.67[The clonidine inhibition test: an aid in the diagnosis and postoperative therapeutic control in pheochromocytoma]. ( Schofer, J; Tews, A, 1985)
"23 patients presenting with symptoms of pheochromocytoma were subjected to the clonidine suppression test."3.67Preliminary results with the clonidine suppression test in the diagnosis of pheochromocytoma. ( Beyer, J; Brandstetter, K; Krause, U, 1985)
"To investigate the possible release of beta-endorphins (beta EN) from tumors and to investigate their possible involvement in the hypotensive mechanism of clonidine (CLO) in pheochromocytoma (PHEO), as compared with essential hypertension (EH), we studied 12 patients with PHEO, 17 patients with uncomplicated stable EH (SEH), nine patients with borderline EH (BEH), and seven healthy volunteers (N)."3.67Plasma beta-endorphins and catecholamines before and after clonidine in essential hypertension and pheochromocytoma. ( Chodakowska, J; Chojnowski, K; Feltynowski, T; Januszewicz, W; Lazecki, D; Wocial, B, 1987)
"3 mg oral dose of clonidine hydrochloride (Catapres) was given to twelve patients with varying evidence of familial adrenal medullary hyperplasia and pheochromocytomas from kindreds with Multiple Endocrine Neoplasia type 2 syndrome (MEN-2), seven patients with sporadic pheochromocytomas and six normal subjects."3.67Clonidine-induced suppression of plasma catecholamines in states of adrenal medulla hyperfunction. ( Gross, MD; Shapiro, B; Sisson, JC; Zweifler, A, 1987)
"In the present paper we report our experience on the utility of basal plasma catecholamine (CA) measurement and of the clonidine-suppression test in the diagnosis of pheochromocytoma."3.67Usefulness of basal catecholamine plasma levels and clonidine suppression test in the diagnosis of pheochromocytoma. ( Baldi, E; De Feo, ML; Maggi, M; Mannelli, M; Opocher, G; Pupilli, C; Serio, M; Valenza, T, 1987)
" The clonidine suppression of urinary metanephrines as a criterion for the diagnosis of pheochromocytoma is described."3.67The clonidine test for the diagnosis of pheochromocytoma: the usefulness of urinary metanephrine measurements. ( Andriollo, A; Carvalho, JG; Guerra, EM; Kohlmann, O; Mulinari, RA; Ribeiro, AB; Saad, CI; Zanella, MT, 1987)
"In this study we examined the preoperative value of the clonidine-suppression test in 15 patients with surgically proved pheochromocytomas."3.67Evaluation of the clonidine-suppression test in the diagnosis of pheochromocytoma. ( Beyer, J; Cordes, U; Krause, U; Plewe, G, 1988)
"A clonidine suppression test and the measurement of the catecholamine (noradrenaline and adrenaline) concentration in 24-hour urine were undertaken on 13 patients with benign phaeochromocytoma (PCC), 30 patients with benign hypertension (BHT) and ten healthy, normotensive volunteers."3.67[Diagnostic significance of the clonidine suppression test in suspected pheochromocytoma]. ( Ivens, K; Schürmeyer, T; Stimpel, M; Volkmann, HP; von zur Mühlen, A; Wambach, G, 1988)
"Although originally devised to discriminate between patients with pheochromocytoma and those with elevated plasma catecholamine levels for other reasons, the clonidine suppression test has recently been used in patients with normal resting catecholamine levels."3.67Reduced specificity of the clonidine suppression test in patients with normal plasma catecholamine levels. ( Elliott, WJ; Murphy, MB, 1988)
"In a prospective study designed to differentiate pheochromocytoma from other forms of hypertension, urinary catecholamines were measured after sleep and clonidine administration in 12 patients with pheochromocytoma, 19 hypertensive patients in whom pheochromocytoma was suspected but later excluded, and 31 hypertensive patients in whom pheochromocytoma was never suspected."3.67Overnight clonidine suppression test in the diagnosis and exclusion of pheochromocytoma. ( Ball, SG; Finlayson, J; Inglis, GC; Isles, CG; Lees, KR; Macdougall, IC; McMillan, NC; Morley, P; Stewart, H; Thomson, I, 1988)
"Baseline plasma norepinephrine (NE) and epinephrine (E) levels over 2000 pg/ml or failure to suppress to less than 500 pg/ml after oral clonidine have been considered diagnostic of the presence of a pheochromocytoma."3.67Clonidine suppression test for pheochromocytoma: examples of misleading results. ( Anton, AH; Mayes, D; Taylor, HC, 1986)
"Fifteen patients with essential hypertension and ten with pheochromocytoma were studied to assess the effect of clonidine, a centrally acting antihypertensive agent, on the functional and biochemical indices of sympathetic function."3.66Effects of clonidine on sympathetic function. ( Bravo, EL, 1983)
"4 patients with hypertensive crisis (glomerulonephritis [n = 2], phaeochromocytoma [n = 1], reno-vascular hypertension [n = 1] combined with encephalopathy, showed a normalisation of blood-pressure up to 18 days during angiotensin-II-blockade with saralasin."3.66[Saralasin in resistant hypertensive crisis (author's transl)]. ( Heidland, A; Röckel, A, 1979)
"1 We have compared, in patients with severe hypertension, the administration of intravenous labetalol by single rapid injection, by repeated bolus injections, and by incremental infusion."3.66Intravenous labetalol in the treatment of severe hypertension. ( Brown, JJ; Cumming, AM; Lever, AF; Robertson, JI, 1982)
"To determine whether the alpha-adrenergic antagonist phenoxybenzamine would alter cardiovascular or plasma catecholamine response to the alpha-adrenergic agonist clonidine, six patients with pheochromocytomas and eight with labile hypertension were studied."3.66Effect of phenoxybenzamine on cardiovascular and plasma catecholamine responses to clonidine. ( Gross, M; Sisson, J; Zweifler, A, 1983)
" Clonidine testing resulted in suppression of plasma norepinephrine levels but was complicated by severe hypotension and a transient ischemic attack."3.66Symptomatic hypotension following the clonidine suppression test for pheochromocytoma. ( Dzau, VJ; Given, BD; Lilly, LS; Taylor, T, 1983)
"Pheochromocytomas are catecholamine-producing tumors, representing one of the most important causes of secondary hypertension."2.40[Clinical and endocrine diagnosis of pheochromocytoma]. ( Kopf, D; Lehnert, H; Mundschenk, J; Schulz, C, 1997)
"The diagnosis of pheochromocytoma has to be based on laboratory tests demonstrating an excess and/or a disregulation in catecholamine (CA) secretion."2.39[Diagnostic problems in pheochromocytoma]. ( Bellini, F; Ianni, L; Lanzillotti, R; Mannelli, M; Pupilli, C, 1995)
"The clonidine test was very useful, particularly for cases where biochemical results were discrepant."1.30[A comparative study of 9 cases of adrenal pheochromocytoma and 11 cases of extra-adrenal pheochromocytoma]. ( Aliaga Martínez, L; Fernández-Torres, C; Hidalgo Tenorio, C; López de la Torre Casares, M; Mediavilla García, JD; Muros de Fuentes, MA; Peran Mesa, F, 1999)
"The clonidine test was found to be safe and should be preferred to the glucagon test which has to be restricted to very selected patients."1.30Pheochromocytoma in Italy: a multicentric retrospective study. ( Cilotti, A; Conti, A; Ianni, L; Mannelli, M, 1999)
"Hypertension due to pheochromocytoma is generally considered to be a straightforward, direct consequence of the elevated concentrations of circulating catecholamines."1.27Role of the sympathetic nervous system in the maintenance of hypertension in rats harboring pheochromocytoma. ( Hoffman, BB; Maze, M; Prokocimer, PG, 1987)
"6 Labetalol is a useful addition to the medical treatment of phaeochromocytoma."1.26Treatment of phaeochromocytoma and of clonidine withdrawal hypertension with labetalol. ( Brown, JJ; Lever, AF; Robertson, AS; Robertson, JI; Rosei, EA; Trust, PM, 1976)

Research

Studies (92)

TimeframeStudies, this research(%)All Research%
pre-199051 (55.43)18.7374
1990's24 (26.09)18.2507
2000's8 (8.70)29.6817
2010's7 (7.61)24.3611
2020's2 (2.17)2.80

Authors

AuthorsStudies
Tsiomidou, S1
Pamporaki, C2
Geroula, A1
Van Baal, L1
Weber, F1
Dralle, H2
Schmid, KW1
Führer, D1
Unger, N1
Remde, H1
Quinkler, M1
Nölting, S1
Prejbisz, A1
Timmers, HJLM1
Masjkur, J1
Fuss, CT1
Fassnacht, M1
Eisenhofer, G3
Deutschbein, T1
Wan, W1
Nguyen, B1
Graybill, S1
Kim, J1
Garcha, AS1
Cohen, DL1
Goupil, R1
Fountoulakis, S1
Gordon, RD4
Stowasser, M1
Fitzgerald, PJ1
Bisschop, PH1
Corssmit, EP1
Baas, SJ1
Serlie, MJ1
Endert, E1
Wiersinga, WM1
Fliers, E1
McHenry, CM1
Hunter, SJ2
McCormick, MT1
Russell, CF1
Smye, MG1
Atkinson, AB2
Yeshayahu, Y1
Tallett, S1
Pacak, K2
De Souza, C1
Palmert, MR1
Lee, GR1
Johnston, PC1
McKillop, D1
Auld, P1
Därr, R1
Lenders, JW2
Stange, K1
Kindel, B1
Hofbauer, LC1
Bornstein, SR1
Bravo, EL6
Shargorodsky, M1
Zimlichman, R1
Goldstein, DS2
Walther, MM1
Friberg, P1
Keiser, HR3
Sartori, M1
Cosenzi, A1
Bernobich, E1
Calo, LA1
Bellini, G1
Semplicini, A1
Levinson, PD1
Lance, BK1
Kowarski, AA1
Hamilton, BP1
Martin, DE1
Kammerer, WS1
Gifford, RW2
Prichard, BN1
Itskovitz, HD1
Reid, JL1
Meredith, PA1
Elliott, HL1
Given, BD1
Taylor, T1
Lilly, LS1
Dzau, VJ1
Dupont, AG2
Velkeniers, B1
Somers, G2
Gerlo, E2
Vanhaelst, L2
Zweifler, A2
Gross, M1
Sisson, J1
Gáspár, L2
Kiss, Z2
Iványi, T2
Lászlé, FA1
Cumming, AM1
Brown, JJ4
Lever, AF4
Robertson, JI4
Burris, JF1
D'Angelo, LJ1
Collart, F1
Tarazi, RC1
Fouad, FM1
Vidt, DG1
McClean, DR1
Sinclair, LM1
Yandle, TG1
Nicholls, MG1
Mannelli, M4
Pupilli, C3
Lanzillotti, R2
Ianni, L3
Bellini, F1
Nardecchia, A1
Turturro, N1
Noviello, F1
Vernaglione, L1
Pirrelli, A1
Amorosi, A1
Credi, G1
Pratesi, C1
Vincent, D1
Pradalier, A1
Rivero Marcotegui, A1
Grijalba Uche, A1
Palacios Sarrasqueta, M1
Garcia Merlo, S1
Sasaki, M1
Naomi, S1
Iwaoka, T1
Lehnert, H1
Schulz, C1
Mundschenk, J1
Kopf, D1
Lenz, T2
Ross, A1
Schumm-Draeger, P1
Schulte, KL2
Geiger, H1
Hug, B1
Mediavilla García, JD2
López de la Torre Casares, M2
Hidalgo Tenorio, C2
Fernández-Torres, C2
Aliaga Martínez, L1
Peran Mesa, F1
Muros de Fuentes, MA1
Cilotti, A1
Conti, A1
León-Ruiz, L1
Piédrola Maroto, G1
Pinel Julián, P1
Jiménez-Alonso, J1
Edwards, L1
Fishman, D1
Horowitz, P1
Bourbon, N1
Kester, M1
Ernsberger, P1
Rosei, EA3
Fraser, R1
Morton, JJ1
Trust, PM3
Röckel, A1
Heidland, A1
Hengstmann, JH1
Dengler, HJ1
Rahn, KH1
Haas, Th1
Denkl, P1
Robertson, AS2
Thiede, HM1
Nussberger, J1
Atlas, SA1
Distler, A1
Becker, G1
Jockenhövel, F1
Bauer, R1
Lederbogen, S1
Lange, R1
Reinwein, D1
Sjoberg, RJ1
Simcic, KJ1
Kidd, GS1
Grossman, E1
Hoffman, A1
Bachmann, AW2
Atzeni, V1
Maccioni, G1
Fiorenza, M1
Bernasconi, M1
Beni, M1
Chojnowski, K2
Feltynowski, T2
Lazecki, D2
Bar-Andziak, E1
Ignatowska-Switalska, H1
Wocial, B2
Koshida, H1
Miyamori, I1
Soma, R1
Matsubara, T1
Okamoto, S1
Ikeda, M1
Takeda, R1
Poliak, M1
Horký, K1
Kopecká, J1
Gregorová, I1
Dvoráková, J1
Eisenhut, S1
Rascher, W1
Lang, RE1
Chodakowska, J1
Januszewicz, W1
Hawkins, PG1
Gatti, G2
Madeddu, L1
Pandiella, A1
Pozzan, T2
Meldolesi, J2
Ambrosini, A1
Westhead, EW1
Grabensee, B1
Gross, MD1
Shapiro, B1
Sisson, JC1
De Feo, ML1
Maggi, M1
Opocher, G1
Valenza, T1
Baldi, E1
Serio, M1
Tunny, TJ1
Klemm, SA1
Plewe, G1
Krause, U2
Cordes, U1
Beyer, J2
Schürmeyer, T2
Schuppert, F1
von zur Mühlen, A2
Stimpel, M1
Ivens, K1
Wambach, G1
Volkmann, HP1
Elliott, WJ1
Murphy, MB1
Macdougall, IC1
Isles, CG1
Stewart, H1
Inglis, GC1
Finlayson, J1
Thomson, I1
Lees, KR1
McMillan, NC1
Morley, P1
Ball, SG1
Karlberg, BE2
Hedman, L2
Prokocimer, PG1
Maze, M1
Hoffman, BB1
Feldstein, JS1
Mulinari, RA1
Zanella, MT1
Guerra, EM1
Kohlmann, O1
Saad, CI1
Andriollo, A1
Carvalho, JG1
Ribeiro, AB1
Taylor, HC1
Mayes, D1
Anton, AH1
Lennquist, S1
Pollare, T1
Cryer, PE1
Frewin, DB1
Cerasola, G1
Marozzi, P1
Morici, ML1
Cottone, S1
D'Ignoto, G1
Grasso, L1
Bompiani, GD1
Schofer, J1
Tews, A1
Vanderniepen, P1
in't Veld, P1
Gepts, W1
Sacre, R1
Six, RO1
Faredin, I1
László, F1
Brandstetter, K1
Philipp, T1
Nast, HP1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Phase II Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Metastatic, Recurrent or Primary Unresectable Pheochromocytoma/Paraganglioma[NCT01967576]Phase 214 participants (Actual)Interventional2013-10-19Completed
Diagnosis and Treatment of Pheochromocytoma[NCT00001229]240 participants Observational1988-10-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Number of Participants With Serious and Non-serious Adverse Events Assessed by the Common Terminology Criteria in Adverse Events (CTCAE v4.0)

Here is the count of participants with serious and non-serious adverse events assessed by the Common Terminology Criteria in Adverse Events (CTCAE v4.0). A non-serious adverse event is any untoward medical occurrence. A serious adverse event is an adverse event or suspected adverse reaction that results in death, a life threatening adverse drug experience, hospitalization, disruption of the ability to conduct normal life functions, congenital anomaly/birth defect or important medical events that jeopardize the patient or subject and may require medical or surgical intervention to prevent one of the previous outcomes mentioned. (NCT01967576)
Timeframe: Date treatment consent signed to date off study, approximately 54 months and 29 days.

InterventionParticipants (Count of Participants)
1/Arm 1-Axitinib14

Progression - Free Survival (PFS)

PFS is defined as the duration of time from start of treatment to time of progression or death, whichever comes first. Disease progression was assessed by the Response Evaluation Criteria in Solid Tumors (RECIST) and is defined as at least a 20% increase in the sum of the diameters of target lesions, taking as reference the smallest sum on study (this includes the baseline sum if that is the smallest on study). In addition to the relative increase of 20%, the sum must also demonstrate an absolute increase of at least 5 mm. (Note: the appearance of one or more new lesions is also considered progressions). (NCT01967576)
Timeframe: time from start of treatment to time of progression or death, up to 5 years and 9 months

Interventionmonths (Median)
1/Arm 1-Axitinib7.7

Number of Participants With Clinical Response (Partial Response + Complete Response)

Response was assessed by the Response Evaluation Criteria in Solid Tumors (RECIST). Partial Response (PR) is at least a 30% decrease in the sum of the diameters of target lesions, taking as reference the baseline sum diameters. Complete Response (CR) is disappearance of all target lesions. Any pathological lymph nodes (whether target or no-target) must have reduction in short axis to <10 mm. Stable Disease (SD) is neither sufficient shrinkage to qualify for PR nor sufficient increase to qualify for PD, taking as reference the smallest sum diameters while on study. Progressive Disease (PD) is at least a 20% increase in the sum of the diameters of target lesions, taking as reference the smallest sum on study (this includes the baseline sum if that is the smallest on study). (NCT01967576)
Timeframe: Patients were assessed every 12 weeks (+/- week) up to 40.6 months

InterventionParticipants (Count of Participants)
Confirmed Partial ResponseComplete ResponseStable DiseaseProgressive Disease
1/Arm 1-Axitinib5052

Reviews

15 reviews available for clonidine and Pheochromocytoma

ArticleYear
Catecholamine excess: pseudopheochromocytoma and beyond.
    Advances in chronic kidney disease, 2015, Volume: 22, Issue:3

    Topics: Adrenal Gland Neoplasms; Adrenergic Agents; Antihypertensive Agents; Autonomic Nervous System Diseas

2015
Is norepinephrine an etiological factor in some types of cancer?
    International journal of cancer, 2009, Jan-15, Volume: 124, Issue:2

    Topics: Animals; Anticarcinogenic Agents; Clonidine; Humans; Models, Biological; Neoplasms; Norepinephrine;

2009
Pheochromocytoma: an approach to antihypertensive management.
    Annals of the New York Academy of Sciences, 2002, Volume: 970

    Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Antihypertensive

2002
The hypertensive surgical patient. Controversies in management.
    The Surgical clinics of North America, 1983, Volume: 63, Issue:5

    Topics: Adrenal Gland Neoplasms; Adrenergic beta-Antagonists; Adult; Anesthesia; Animals; Antihypertensive A

1983
Current concepts. Pheochromocytoma: diagnosis, localization and management.
    The New England journal of medicine, 1984, Nov-15, Volume: 311, Issue:20

    Topics: Adrenal Gland Neoplasms; Adrenergic beta-Antagonists; Blood Pressure; Catecholamines; Clonidine; Glu

1984
Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
    Drugs, 1984, Volume: 28 Suppl 2

    Topics: Administration, Oral; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthesia; Antihyp

1984
Clonidine and the kidney.
    Journal of cardiovascular pharmacology, 1980, Volume: 2 Suppl 1

    Topics: Adrenal Gland Neoplasms; Aldosterone; Antihypertensive Agents; Catecholamines; Clonidine; Humans; Hy

1980
Labetalol and the management of hypertension.
    Journal of cardiovascular pharmacology, 1981, Volume: 3 Suppl 1

    Topics: Adrenal Gland Neoplasms; Clonidine; Ethanolamines; Humans; Hypertension; Labetalol; Pheochromocytoma

1981
[Diagnostic problems in pheochromocytoma].
    Minerva endocrinologica, 1995, Volume: 20, Issue:1

    Topics: 3-Iodobenzylguanidine; Adrenal Cortex Neoplasms; Algorithms; Biomarkers; Catecholamines; Clonidine;

1995
[Laboratory contribution to the diagnosis of pheochromocytoma].
    Anales de medicina interna (Madrid, Spain : 1984), 1996, Volume: 13, Issue:1

    Topics: Adrenal Gland Neoplasms; Biochemical Phenomena; Biochemistry; Biomarkers; Catecholamines; Chromatogr

1996
[Clonidine suppression test].
    Nihon rinsho. Japanese journal of clinical medicine, 1997, Volume: 55 Suppl 2

    Topics: Adrenal Gland Neoplasms; Adrenal Medulla; Clonidine; Humans; Pheochromocytoma

1997
[Clinical and endocrine diagnosis of pheochromocytoma].
    Zentralblatt fur Chirurgie, 1997, Volume: 122, Issue:6

    Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Catecholamines; Clonidine; Humans; Iodine Radioisoto

1997
Clonidine suppression test revisited.
    Blood pressure, 1998, Volume: 7, Issue:3

    Topics: Adrenal Gland Neoplasms; Adult; Aged; Clonidine; Creatinine; Epinephrine; Female; Hemodynamics; Huma

1998
[Influence of antihypertensive agents on catecholamine and metabolite excretion and its significance for the diagnosis of pheochromocytoma].
    Deutsche medizinische Wochenschrift (1946), 1975, Nov-07, Volume: 100, Issue:45

    Topics: Adrenal Gland Neoplasms; Adrenergic beta-Antagonists; Antihypertensive Agents; Catecholamines; Cloni

1975
Phaeochromocytoma.
    Clinics in endocrinology and metabolism, 1985, Volume: 14, Issue:1

    Topics: Adrenal Gland Neoplasms; Adrenal Glands; Blood Pressure; Chromaffin Granules; Chromatography, High P

1985

Trials

1 trial available for clonidine and Pheochromocytoma

ArticleYear
Clonidine suppression test for a reliable diagnosis of pheochromocytoma: When to use.
    Clinical endocrinology, 2022, Volume: 97, Issue:5

    Topics: Adrenal Gland Neoplasms; Clonidine; Humans; Hypertension; Metanephrine; Normetanephrine; Paraganglio

2022

Other Studies

76 other studies available for clonidine and Pheochromocytoma

ArticleYear
Improved Diagnostic Accuracy of Clonidine Suppression Testing Using an Age-Related Cutoff for Plasma Normetanephrine.
    Hypertension (Dallas, Tex. : 1979), 2022, Volume: 79, Issue:6

    Topics: Adrenal Gland Neoplasms; Clonidine; Humans; Metanephrine; Normetanephrine; Paraganglioma; Pheochromo

2022
Clonidine suppression testing for pheochromocytoma in neurofibromatosis type 1.
    BMJ case reports, 2019, Jun-25, Volume: 12, Issue:6

    Topics: Adrenal Gland Neoplasms; Adrenergic alpha-2 Receptor Agonists; Clonidine; False Positive Reactions;

2019
Urinary clonidine suppression testing for the diagnosis of pheochromocytoma.
    Journal of hypertension, 2015, Volume: 33, Issue:11

    Topics: Adrenal Gland Neoplasms; Adult; Catecholamines; Clonidine; Female; Humans; Male; Metanephrine; Middl

2015
Evaluation of Endocrine Tests. C: glucagon and clonidine test in phaeochromocytoma.
    The Netherlands journal of medicine, 2009, Volume: 67, Issue:3

    Topics: Adrenal Gland Neoplasms; Adult; Aged; Catecholamines; Clonidine; Female; Glucagon; Humans; Male; Mid

2009
Evaluation of the clonidine suppression test in the diagnosis of phaeochromocytoma.
    Journal of human hypertension, 2011, Volume: 25, Issue:7

    Topics: Adrenal Gland Neoplasms; Antihypertensive Agents; Catecholamines; Clonidine; Diagnostic Tests, Routi

2011
When is a phaeo not a phaeo? Depression in an adolescent leading to a phaeochromocytoma-like biochemical profile.
    Clinical endocrinology, 2011, Volume: 75, Issue:4

    Topics: Adolescent; Adrenal Gland Neoplasms; Catecholamines; Clonidine; Depression; Humans; Male; Pheochromo

2011
A comparison of plasma-free metanephrines with plasma catecholamines in the investigation of suspected pheochromocytoma.
    Journal of hypertension, 2011, Volume: 29, Issue:12

    Topics: Adrenal Gland Neoplasms; Antihypertensive Agents; Catecholamines; Chromatography, High Pressure Liqu

2011
[Diagnosis of pheochromocytoma and paraganglioma: the clonidine suppression test in patients with borderline elevations of plasma free normetanephrine].
    Deutsche medizinische Wochenschrift (1946), 2013, Volume: 138, Issue:3

    Topics: Adrenal Gland Neoplasms; Adult; Aged; Biomarkers; Clonidine; Female; Humans; Male; Middle Aged; Norm

2013
Pheochromocytoma: a disease with many faces.
    The Israel Medical Association journal : IMAJ, 2002, Volume: 4, Issue:10

    Topics: Adrenal Gland Neoplasms; Catecholamines; Chromatography, High Pressure Liquid; Clonidine; Diagnosis,

2002
Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test results.
    The Journal of clinical endocrinology and metabolism, 2003, Volume: 88, Issue:6

    Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Adult; Antidepressive Agents, Tricyclic; Bioc

2003
A pheochromocytoma with normal clonidine-suppression test: how difficult the biochemical diagnosis?
    Internal and emergency medicine, 2008, Volume: 3, Issue:1

    Topics: Catecholamines; Clonidine; Diagnosis, Differential; Humans; Hypertension; Male; Metanephrine; Middle

2008
Catecholamine suppression testing in patient with phaechromocytoma and normal plasma catecholamine levels.
    Lancet (London, England), 1983, May-28, Volume: 1, Issue:8335

    Topics: Adrenal Gland Neoplasms; Clonidine; Epinephrine; Humans; Male; Norepinephrine; Pheochromocytoma; Ref

1983
Effects of clonidine on sympathetic function.
    Chest, 1983, Volume: 83, Issue:2 Suppl

    Topics: Adrenal Gland Neoplasms; Blood Pressure; Clonidine; Heart Rate; Humans; Hypertension; Norepinephrine

1983
Pheochromocytoma. Current concepts in diagnosis, localization, and management.
    Primary care, 1983, Volume: 10, Issue:1

    Topics: Adrenal Gland Neoplasms; Adult; Blood Pressure; Catecholamines; Child; Clonidine; Female; Humans; Hy

1983
Symptomatic hypotension following the clonidine suppression test for pheochromocytoma.
    Archives of internal medicine, 1983, Volume: 143, Issue:11

    Topics: Adrenal Gland Neoplasms; Adult; Clonidine; Humans; Hypotension; Male; Pheochromocytoma

1983
Unusual clonidine-suppression test in an epinephrine-secreting pheochromocytoma.
    The New England journal of medicine, 1984, Jan-26, Volume: 310, Issue:4

    Topics: Adrenal Gland Neoplasms; Adult; Animals; Clonidine; Epinephrine; Humans; Male; Pheochromocytoma; Rat

1984
Effect of phenoxybenzamine on cardiovascular and plasma catecholamine responses to clonidine.
    Clinical pharmacology and therapeutics, 1983, Volume: 33, Issue:2

    Topics: Blood Pressure; Clonidine; Drug Interactions; Epinephrine; Humans; Hypertension; Norepinephrine; Phe

1983
Clonidine-suppression test for diagnosis of pheochromocytoma.
    The New England journal of medicine, 1982, Jan-07, Volume: 306, Issue:1

    Topics: Adrenal Gland Neoplasms; Adult; Clonidine; Humans; Male; Pentolinium Tartrate; Pheochromocytoma

1982
Clonidine suppression test in pheochromocytoma.
    The New England journal of medicine, 1982, Jul-15, Volume: 307, Issue:3

    Topics: Adrenal Gland Neoplasms; Clonidine; Epinephrine; Humans; Norepinephrine; Pheochromocytoma

1982
Intravenous labetalol in the treatment of severe hypertension.
    British journal of clinical pharmacology, 1982, Volume: 13, Issue:1 Suppl

    Topics: Adrenal Gland Neoplasms; Catecholamines; Clonidine; Ethanolamines; Humans; Hypertension; Infusions,

1982
Complications of clonidine suppression test for pheochromocytoma.
    The New England journal of medicine, 1982, Sep-16, Volume: 307, Issue:12

    Topics: Adrenal Gland Neoplasms; Clonidine; Female; Humans; Hypertension; Male; Middle Aged; Pheochromocytom

1982
[Plasma catecholamine assay in arterial hypertension].
    Revue medicale de Bruxelles, 1982, Volume: 3, Issue:10

    Topics: Chromatography, High Pressure Liquid; Clonidine; Epinephrine; Humans; Hypertension; Norepinephrine;

1982
Clonidine-suppression test: a useful aid in the diagnosis of pheochromocytoma.
    The New England journal of medicine, 1981, Sep-10, Volume: 305, Issue:11

    Topics: Adrenal Gland Neoplasms; Blood Pressure; Clonidine; Epinephrine; Heart Rate; Humans; Norepinephrine;

1981
Malignant phaeochromocytoma with high circulating DOPA, and clonidine-suppressible noradrenaline.
    Blood pressure, 1995, Volume: 4, Issue:4

    Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Agonists; Aged; Clonidine; Dihydroxyphenylalanine; Humans;

1995
Positive responses to clonidine test in nephrovascular hypertension: only a false positive?
    Recenti progressi in medicina, 1994, Volume: 85, Issue:10

    Topics: Adrenal Gland Neoplasms; Adult; Clonidine; False Positive Reactions; Female; Humans; Hyperaldosteron

1994
A nonsecreting pheochromocytoma presenting as an incidental adrenal mass. Report on a case.
    Journal of endocrinological investigation, 1993, Volume: 16, Issue:10

    Topics: Adrenal Gland Neoplasms; Adult; Blood Pressure; Catecholamines; Clonidine; Female; Glucagon; Heart R

1993
Pheochromocytoma-like catecholamine levels induced by clonidine cessation.
    The European journal of medicine, 1993, Volume: 2, Issue:5

    Topics: Catecholamines; Clonidine; Humans; Hypertension; Male; Middle Aged; Pheochromocytoma; Substance With

1993
[Panic disorder].
    Praxis, 1998, Dec-03, Volume: 87, Issue:49

    Topics: Adrenal Gland Neoplasms; Aged; Clonidine; Diagnosis, Differential; Epinephrine; Female; Humans; Nore

1998
[A comparative study of 9 cases of adrenal pheochromocytoma and 11 cases of extra-adrenal pheochromocytoma].
    Revista clinica espanola, 1999, Volume: 199, Issue:6

    Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Adrenal Gland Neoplasms; Adrenergic alpha-Agonists; Adul

1999
Pheochromocytoma in Italy: a multicentric retrospective study.
    European journal of endocrinology, 1999, Volume: 141, Issue:6

    Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Child; Clonidine; Epinephrine;

1999
[Usefulness of the clonidine test for the diagnosis of pheochromocytoma].
    Revista clinica espanola, 2001, Volume: 201, Issue:5

    Topics: Adrenal Gland Neoplasms; Adult; Catecholamines; Clonidine; Female; Humans; Male; Middle Aged; Pheoch

2001
The I1-imidazoline receptor in PC12 pheochromocytoma cells activates protein kinases C, extracellular signal-regulated kinase (ERK) and c-jun N-terminal kinase (JNK).
    Journal of neurochemistry, 2001, Volume: 79, Issue:5

    Topics: Adrenergic alpha-Agonists; Animals; Blotting, Western; Cell Division; Clonidine; Enzyme Activation;

2001
Labetalol (AH5158), a competitive alpha- and beta-receptor blocking drug, in the management of hypertension.
    Australian and New Zealand journal of medicine, 1976, Volume: 6, Issue:3 Suppl

    Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aldosterone; Angiotensin II; Cloni

1976
[Saralasin in resistant hypertensive crisis (author's transl)].
    Medizinische Klinik, 1979, Mar-16, Volume: 74, Issue:11

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin II; Clonidine; Female; Furosemide; Glomerulone

1979
[Therapy of hypertensive crisis].
    Verhandlungen der Deutschen Gesellschaft fur Kreislaufforschung, 1977, Volume: 43

    Topics: Acute Disease; Adrenal Gland Neoplasms; Antihypertensive Agents; Clonidine; Diazoxide; Dihydralazine

1977
[Therapy of hypertensive crises].
    Fortschritte der Medizin, 1977, Apr-21, Volume: 95, Issue:15

    Topics: Acute Disease; Adrenal Gland Neoplasms; Antihypertensive Agents; Clonidine; Diazoxide; Dihydralazine

1977
Treatment of phaeochromocytoma and of clonidine withdrawal hypertension with labetalol.
    British journal of clinical pharmacology, 1976, Volume: 3, Issue:4 Suppl 3

    Topics: Administration, Oral; Adult; Clonidine; Drug Evaluation; Ethanolamines; Female; Humans; Hypertension

1976
Letter: Emergency treatment of hypertensive crisis following clonidine withdrawal.
    British medical journal, 1976, May-29, Volume: 1, Issue:6021

    Topics: Clonidine; Humans; Hypertension; Labetalol; Pheochromocytoma; Substance Withdrawal Syndrome

1976
Hyperreninemia and secondary hyperaldosteronism in a patient with pheochromocytoma and von Hippel-Lindau disease.
    Nephron, 1992, Volume: 62, Issue:3

    Topics: Adrenal Gland Neoplasms; Adult; Captopril; Catecholamines; Clonidine; Female; Humans; Hyperaldostero

1992
Cervical pheochromocytoma: a rare localization and a difficult diagnosis.
    Journal of endocrinological investigation, 1992, Volume: 15, Issue:10

    Topics: Adrenal Gland Neoplasms; Catecholamines; Clonidine; Female; Glucagon; Humans; Middle Aged; Pheochrom

1992
The clonidine suppression test for pheochromocytoma. A review of its utility and pitfalls.
    Archives of internal medicine, 1992, Volume: 152, Issue:6

    Topics: Adrenal Gland Neoplasms; Aged; Clonidine; Evaluation Studies as Topic; Humans; Male; Neoplasms, Mult

1992
Pheochromocytoma: new concepts and future trends.
    Kidney international, 1991, Volume: 40, Issue:3

    Topics: Acidosis, Lactic; Adrenal Gland Neoplasms; Adult; Animals; Antihypertensive Agents; Antineoplastic C

1991
Surreptitious self-administration of epinephrine resulting in 'pheochromocytoma'.
    JAMA, 1991, Sep-18, Volume: 266, Issue:11

    Topics: Adrenal Gland Neoplasms; Adult; Clonidine; Epinephrine; Factitious Disorders; Female; Humans; Muncha

1991
Glucagon and clonidine testing in the diagnosis of pheochromocytoma.
    Hypertension (Dallas, Tex. : 1979), 1991, Volume: 17, Issue:6 Pt 1

    Topics: Adrenal Gland Neoplasms; Catechols; Clonidine; Drug Therapy, Combination; Glucagon; Humans; Hyperten

1991
Clonidine suppression test reliably differentiates phaeochromocytoma from essential hypertension.
    Clinical and experimental pharmacology & physiology, 1991, Volume: 18, Issue:5

    Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Clonidine; Diagnosis, Differential; Epinephrine; F

1991
[Pheochromocytoma diagnosed during quinapril therapy].
    Minerva cardioangiologica, 1990, Volume: 38, Issue:10

    Topics: Adrenal Gland Neoplasms; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Clonidin

1990
[Correlations between catecholamines and prostaglandins in patients with primary arterial hypertension and pheochromocytoma in basic conditions and after administration of clonidine].
    Kardiologia polska, 1990, Volume: 33, Issue:6

    Topics: Adrenal Gland Neoplasms; Adult; Clonidine; Dinoprost; Dinoprostone; Epinephrine; Humans; Hypertensio

1990
Evaluation of clonidine suppression and various provocation tests in the diagnosis of pheochromocytoma.
    Journal of endocrinological investigation, 1990, Volume: 13, Issue:10

    Topics: Adrenal Gland Neoplasms; Adult; Aged; Blood Pressure; Clonidine; Epinephrine; Female; Glucagon; Huma

1990
[The effect of clonidine on humoral factors in patients with arterial hypertension].
    Casopis lekaru ceskych, 1990, Mar-09, Volume: 129, Issue:10

    Topics: Adrenal Gland Neoplasms; Aldosterone; Atrial Natriuretic Factor; Catecholamines; Clonidine; Diagnosi

1990
[Bilateral adrenal pheochromocytoma. Diagnosis and follow-up using the clonidine test and measurement of plasma neuropeptide Y concentration].
    Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde, 1990, Volume: 138, Issue:9

    Topics: Adrenal Gland Neoplasms; Child; Clonidine; Female; Humans; Neoplasms, Multiple Primary; Neuropeptide

1990
Plasma beta-endorphins and catecholamines before and after clonidine in essential hypertension and pheochromocytoma.
    Journal of cardiovascular pharmacology, 1987, Volume: 10 Suppl 12

    Topics: Adrenal Gland Neoplasms; Adult; beta-Endorphin; Blood Pressure; Catecholamines; Clonidine; Dopamine;

1987
Phaeochromocytomas secreting adrenaline but not noradrenaline do not cause hypertension and require precise adrenaline measurement for diagnosis.
    Clinical and experimental pharmacology & physiology, 1989, Volume: 16, Issue:4

    Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Chromatography, High Pressure Liquid; Clonidine; E

1989
Second-messenger generation in PC12 cells. Interactions between cyclic AMP and Ca2+ signals.
    The Biochemical journal, 1988, Nov-01, Volume: 255, Issue:3

    Topics: Animals; Calcium; Carbachol; Cell Differentiation; Cell Line; Clonidine; Cyclic AMP; Imidazoles; Ner

1988
Second-messenger control of catecholamine release from PC12 cells. Role of muscarinic receptors and nerve-growth-factor-induced cell differentiation.
    The Biochemical journal, 1988, Nov-01, Volume: 255, Issue:3

    Topics: Adrenal Gland Neoplasms; Animals; Carbachol; Catecholamines; Cell Differentiation; Clonidine; Colfor

1988
[Therapy of the hypertensive crisis].
    Deutsche medizinische Wochenschrift (1946), 1985, Nov-08, Volume: 110, Issue:45

    Topics: Administration, Oral; Adrenergic beta-Antagonists; Calcium Channel Blockers; Clonidine; Dihydralazin

1985
Clonidine-induced suppression of plasma catecholamines in states of adrenal medulla hyperfunction.
    Journal of endocrinological investigation, 1987, Volume: 10, Issue:4

    Topics: Adolescent; Adrenal Gland Diseases; Adrenal Medulla; Adult; Blood Pressure; Catecholamines; Clonidin

1987
Usefulness of basal catecholamine plasma levels and clonidine suppression test in the diagnosis of pheochromocytoma.
    Journal of endocrinological investigation, 1987, Volume: 10, Issue:4

    Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Catecholamines; Clonidine; Epinephrine; Female; Hu

1987
Effects of angiotensin and noradrenaline on atrial natriuretic peptide levels in man.
    Clinical and experimental pharmacology & physiology, 1987, Volume: 14, Issue:3

    Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Angiotensin II; Atrial Natriuretic Factor; Clonidi

1987
Evaluation of the clonidine-suppression test in the diagnosis of pheochromocytoma.
    Klinische Wochenschrift, 1988, Sep-01, Volume: 66, Issue:17

    Topics: Adrenal Gland Neoplasms; Adult; Clonidine; Epinephrine; Female; Humans; Male; Middle Aged; Norepinep

1988
[Preoperative diagnosis of suspected pheochromocytoma--retrospective assessment of diagnostic criteria].
    Acta medica Austriaca, 1988, Volume: 15, Issue:4

    Topics: Adrenal Gland Neoplasms; Adult; Aged; Clonidine; Diagnostic Imaging; Dopamine; Epinephrine; Female;

1988
[Diagnostic significance of the clonidine suppression test in suspected pheochromocytoma].
    Deutsche medizinische Wochenschrift (1946), 1988, Jan-29, Volume: 113, Issue:4

    Topics: Adrenal Cortex Function Tests; Adrenal Gland Neoplasms; Adult; Clonidine; Epinephrine; Evaluation St

1988
Reduced specificity of the clonidine suppression test in patients with normal plasma catecholamine levels.
    The American journal of medicine, 1988, Volume: 84, Issue:3 Pt 1

    Topics: Adrenal Gland Neoplasms; Clonidine; False Positive Reactions; Humans; Norepinephrine; Pheochromocyto

1988
Overnight clonidine suppression test in the diagnosis and exclusion of pheochromocytoma.
    The American journal of medicine, 1988, Volume: 84, Issue:6

    Topics: Adrenal Gland Neoplasms; Adult; Aged; Blood Pressure; Catecholamines; Clonidine; Female; Humans; Mal

1988
Value of the clonidine suppression test in the diagnosis of pheochromocytoma.
    Acta medica Scandinavica. Supplementum, 1986, Volume: 714

    Topics: Adrenal Gland Neoplasms; Adult; Blood Pressure; Catecholamines; Clonidine; Dopamine; Epinephrine; Hu

1986
Role of the sympathetic nervous system in the maintenance of hypertension in rats harboring pheochromocytoma.
    The Journal of pharmacology and experimental therapeutics, 1987, Volume: 241, Issue:3

    Topics: Adrenal Gland Neoplasms; Animals; Chlorisondamine; Clonidine; Hypertension; Naloxone; Pheochromocyto

1987
Hypertensive emergencies.
    Primary care, 1986, Volume: 13, Issue:1

    Topics: Adrenal Gland Neoplasms; Angina Pectoris; Antihypertensive Agents; Aortic Aneurysm; Aortic Dissectio

1986
The clonidine test for the diagnosis of pheochromocytoma: the usefulness of urinary metanephrine measurements.
    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 1987, Volume: 20, Issue:1

    Topics: Adrenal Gland Neoplasms; Blood Pressure; Clonidine; Epinephrine; Humans; Metanephrine; Pheochromocyt

1987
Clonidine suppression test for pheochromocytoma: examples of misleading results.
    The Journal of clinical endocrinology and metabolism, 1986, Volume: 63, Issue:1

    Topics: Adrenal Gland Neoplasms; Adrenal Medulla; Catecholamines; Clonidine; Epinephrine; False Negative Rea

1986
The value of the clonidine-suppression test in the diagnosis of pheochromocytoma.
    World journal of surgery, 1986, Volume: 10, Issue:5

    Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Blood Pressure; Catecholamines; Clonidine; Female;

1986
Clonidine. Quo vadis?
    The Medical journal of Australia, 1985, Feb-18, Volume: 142, Issue:4

    Topics: Adrenal Gland Neoplasms; Anxiety Disorders; Climacteric; Clonidine; Female; Humans; Hypertension; Mi

1985
[Scintigraphy with 131I-metaiodobenzylguanidine in the differential diagnosis of pheochromocytoma].
    Recenti progressi in medicina, 1985, Volume: 76, Issue:3

    Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Clonidine; Humans; Hypertension; Iodine Radioisotope

1985
[The clonidine inhibition test: an aid in the diagnosis and postoperative therapeutic control in pheochromocytoma].
    Deutsche medizinische Wochenschrift (1946), 1985, Sep-13, Volume: 110, Issue:37

    Topics: Adult; Blood Pressure Determination; Clonidine; Epinephrine; Female; Humans; Liver Neoplasms; Male;

1985
Clonidine-suppression test in epinephrine secreting pheochromocytoma: report of a case.
    Journal of endocrinological investigation, 1985, Volume: 8, Issue:2

    Topics: Adrenal Gland Neoplasms; Adult; Clonidine; Cytoplasmic Granules; Epinephrine; Humans; Male; Microsco

1985
[The clonidine suppression test in pheochromocytoma].
    Orvosi hetilap, 1985, Sep-15, Volume: 126, Issue:37

    Topics: Adolescent; Adult; Catecholamines; Clonidine; Female; Humans; Male; Middle Aged; Pheochromocytoma

1985
Preliminary results with the clonidine suppression test in the diagnosis of pheochromocytoma.
    Cardiology, 1985, Volume: 72 Suppl 1

    Topics: Adrenal Gland Neoplasms; Clonidine; Diagnosis, Differential; Epinephrine; Humans; Hypertension; Nore

1985
[Hypertensive emergencies].
    Der Internist, 1974, Volume: 15, Issue:3

    Topics: Brain Edema; Clonidine; Diazoxide; Digitalis Glycosides; Diuretics; Drug Combinations; Emergencies;

1974